Pages

Thursday, May 5, 2011

PFT


Pulmonary Function Testing

Pulmonary function testing is one of the basic tools for evaluating a patient's respiratory status. In patients with suspected pulmonary disease, it is often the first diagnostic test employed in the work up. Pulmonary function tests (PFT's) are also used for pre-operative evaluation, managing patients with known pulmonary disease, and quantifying pulmonary disability. Although the fully equipped PFT laboratory utilizes a host of sophisticated equipment, simple spirometry is relatively easy to administer and standardize and has become portable enough to use at outreach clinics and industrial health centers. The increasing availability of spirometry has led to greater use by both primary care physicians and specialists, some of whom may lack formal training in interpreting results. This educational module is designed to provide an introduction to quality assessment and basic interpretation of spirometric testing.

Scleroderma

There are an estimated 300,000 people in the United States who have scleroderma, about one third of whom have the systemic form of scleroderma. Since scleroderma presents with symptoms similar to other autoimmune diseases, diagnosis is difficult and there may be many misdiagnosed or undiagnosed cases as well.
Localized scleroderma is more common in children, whereas systemic scleroderma is more common in adults. Overall female patients outnumber male patients about four to one, and the average age at diagnosis is in the forties.
Factors other than sex, such as race and ethnic background, may influence the risk of getting scleroderma, the age of onset, and the pattern or severity of internal organ involvement. The reasons for this are not clear. Although scleroderma is not directly inherited, some scientists feel there is a slight predisposition to it in families with a history of rheumatic diseases.
However, scleroderma can develop and is found in every age group from infants to the elderly, but its onset is most frequent between the ages of 25 to 55. When doctors say "usually" or "for the most part," the reader should understand that variations frequently occur. Many patients get alarmed when they read medical information that seems to contradict their own experiences, and conclude that what has happened to them is not supposed to happen. There are many exceptions to the rules in scleroderma, perhaps more so than in other diseases. Each case is different, and information should be discussed with your own doctor.